Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New research published in The Lancet shows where the fight to defeat malaria is succeeding and where it has stalled. Two studies present the most comprehensive picture to date of the Plasmodium vivax and Plasmodium falciparum parasites, which cause the majority of the world’s malaria burden.

Previous global maps have focused on a single year. These studies chart the change over time from 2000 to 2017, revealing areas of progress and regions where the burden of malaria is still high or increasing. They also show the burden of malaria at a fine local geographic scale, allowing decision-makers to target interventions where the need is greatest.

Read more (University of Oxford website)

Similar stories

Typhoid vaccine trial confirms sustained protection for older children

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.